IL1B and gastric cancer: Inflammasome activation is increasingly recognized in human gastric cancer and autoimmune gastritis, where it contributes to chronic inflammation and tissue damage through IL-1β and IL-18 production (Zeng et al., 2023; Dawson et al., 2023; Man, 2018; Zhou et al., 2024).